Cód QR

Long-term treatment of generalised anxiety disorder with Aviandr: results of a 36-week post-registration observational study

The management of patients with generalised anxiety disorder (GAD) is a pressing issue in modern medicine. A new Russian drug, Aviandr (maritupridine), has demonstrated efficacy and good tolerability in the treatment of GAD in clinical trials.Objective: To study the effectiveness of treating GAD wit...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: M. A. Kinkulkina, B. A. Volel, E. A. Smolyarchuk, E. N. Morozov, A. V. Ivaschenko, A. A. Ivaschenko, N. N. Ivanets, V. G. Zilov, T. I. Avdeeva, Yu. G. Tikhonova, T. A. Izyumina, P. A. Belyaeva, V. A. Dedkova, O. V. Izmailova, D. A. Golovkina, E. M. Goncharova, D. S. Gorchakov, A. E. Morozov, V. V. Tarasov
Formáid: Artigo
Teanga:Russo
Foilsithe / Cruthaithe: IMA-PRESS LLC 2025-12-01
Sraith:Неврология, нейропсихиатрия, психосоматика
Ábhair:
generalised anxiety disorder
therapy
aviandr
efficacy
anxiety
depression
cognitive impairment
Rochtain ar líne:https://nnp.ima-press.net/nnp/article/view/2737
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla